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Abstract. The structures of the class C b-lactamase from
Enterobacter cloacae 908R alone and in complex with a
boronic acid transition-state analogue were determined by
X-ray crystallography at 2.1 and 2.3 Å, respectively. The
structure of the enzyme resembles those of other class C
b-lactamases. The structure of the complex with the tran-
sition-state analogue, iodo-acetamido-phenyl boronic
acid, shows that the inhibitor is covalently bound to the ac-
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tive-site serine (Ser64). Binding of the inhibitor within the
active site is compared with previously determined struc-
tures of complexes with other class C enzymes. The struc-
ture of the boronic acid adduct indicates ways to improve
the affinity of this class of inhibitors. This structure of
908R class C b-lactamase in complex with a transition-
state analogue provides further insights into the mecha-
nism of action of these hydrolases.
The expression of b-lactamases is one of the most com-
mon and well-studied forms of antibiotic resistance. Class
C b-lactamases are among the most challenging of these
enzymes because they are not significantly inhibited by
clinically used b-lactamase inhibitors. Moreover, they have
a broad spectrum of action and can hydrolyse a variety of
substrates, including the third-generation cephalosporins.
Class C b-lactamases hydrolyse their substrates in a four-
step process (fig. 1). Early mutagenesis [1, 3] and struc-
tural [4–6] studies identified key catalytic residues, in-
cluding Ser64, Tyr150, Lys67 and Asn152. 
Subsequent X-ray crystallographic studies investigated
acyl-adduct complexes of the class C enzymes with b-
lactam inhibitors and poor substrates such as aztreonam
(PDB code 1FR6 [4]), moxalactam (PDB code 1FCO [7]),
ceftazidime (PDB code 1IEL [8]), imipenem (PDB code
1LL5 [9]) and a cephem sulphone (PDB code 1GA0 [10]).
These structures revealed key interactions that contribute
to the formation of the acyl-enzyme intermediate. In 
Escherichia coli AmpC, one of the class C b-lactamases
that has been extensively studied, binding to imipenem
(PDB code 1LL5) differs from its binding to moxalactam
(PDB code 1FCO) but is similarly to its binding to TEM1
(PDB code 1BT5), a class A b-lactamase. The less-con-
strained active-site geometry in class C enzymes thus al-
lows different binding modes and, hence, different possi-
ble mechanisms of inhibition. For example, imipenem
appears to act as an inhibitor because, once it has reacted* Corresponding author.
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with the enzyme, the acyl-enzyme adduct formed under-
goes conformational changes that rotate the acyl centre
away from the point of hydrolytic attack [9].
Recently, efforts to capture crystal structures of interme-
diates (pre-covalent enzyme-substrate and post-covalent
enzyme-product) have been undertaken by studying com-
plexes between the S64G mutant AmpC in complex with
the b-lactam cephalothin in its substrate and product
forms (1KVL, 1KVM [11]). These structures of mile-
stones in the reaction pathway of AmpC provide insight
into substrate recognition, catalysis, and product release.
One major conclusion from these structural and mecha-
nistic studies is that the ligand undergoes a dramatic con-
formational change as the reaction progresses. 
Since the X-ray crystal structures of class C b-lactamases
have been determined, these molecules are attractive tar-
gets for novel inhibitor discovery using structure-based
methods [12,13]. The E. coli AmpC enzyme is one of the
class C b-lactamase that has been extensively studied.
Several classes of non-b-lactam inhibitors have been iden-
tified for this protein. Substituted boronic acids have been
prepared leading to irreversible inhibitors with high 
affinity and specificity [14, 15]. Complexes with transi-
tion-state boronic acids [5, 8, 14, 16] and phosphonate in-
hibitors [17] confirmed the possibility of different binding
modes within the binding site of class C b-lactamases.
One concern with this type of boronic acid inhibitors, also
observed with phosphonates [17], is that they form cova-
lent adducts with activated serine nucleophiles, potentially
reducing their selectivity versus other serine active en-
zymes like serine proteases. In an effort to design non-co-
valent, more selective inhibitors of class C b-lactamases,
molecular docking calculation and virtual screening
techniques have been used to identify original molecules,
and novel non-covalent inhibitors of AmpC have emerged
from this structure-based discovery process [18]. The
structure of the enzyme with one of these new inhibitors,
3-[(4-chloroanilino)sulphonyl]thiopene-2-carboxylic acid,
was determined by X-ray crystallography and closely re-
sembled the docking prediction.
As part of this structural approach to class C b-lactamases
giving access to mechanistic and structure-based drug de-
sign studies, we report here the crystal structures of the
wild-type Enterobacter cloacae 908R class C b-lacta-
mase, alone and in complex with iodo-acetamido-phenyl
boronic acid (IAPB; scheme 1). 
Material and methods
Crystallisation, data collection, phase determination
and structure refinement
Crystals of E. cloacae 908R were prepared as described
elsewhere [19]. Crystals of the complex with IAPB, were
obtained by soaking a crystal of the apo enzyme in a sat-
urated solution of the inhibitor in the mother liquor [0.1 M
bicine buffer at pH 9.0 and 30% polyethylene glycol
(Mr = 6000)] 30 min before starting data collection. Crys-
tals were directly flash-frozen from this solution. X-ray
diffraction data were collected at 100 K using a Siemens
X1000 area detector and a Rigaku RU-200 rotating anode
generator as X-ray source. The detector was at a distance
of 130 mm with a 2q angle of 20° and 22° for the 908R-
IAPB complex and the free enzyme, respectively. The data
collection step size was 0.2° between frames, with a count
time of 70 s. per frame. Indexing, integration and scaling
of data sets were carried out using the XENGEN 2.0
package [20].
Figure 1. Four-step process for the hydrolysis of substrates by class C b-lactamases (Enz = enzyme).
Scheme 1. The structure of iodo-acetamido-phenyl boronic acid
(IAPB).
Statistical search
Statistical searches in the Protein Data Bank were per-
formed using Version 4.0 of the Relibase program for
searching protein-ligand databases available on the net
(http://relibase.ccdc.cam.ac.uk). The structure was visu-
alised via a graphical Rasmol-type interface available with
the on-line Relibase tools.
Results and Discussion
Apo structure (unliganded form) of E. cloacae
908R class C b-lactamase
The refined 2.3-Å structure of the E. cloacae P99 enzyme
(PDB code 1BLS [17]) was used as a search model for a
molecular replacement solution using data within the res-
olution range of 10 – 2.5 Å. The 361-amino-acid sequence
of the molecular probe differs by only five mutations. One
clear solution for both the rotation and translation func-
tions was directly obtained with an R factor and a corre-
lation coefficient of 0.28 and 0.804, respectively. The elec-
tron density calculated with the best solution was of very
good quality and clearly showed the mutations to be in-
troduced in the structure of E. cloacae 908R. 
The overall structure of E. cloacae 908R is similar to
those previously reported for other class C b-lactamases,
including E. coli AmpC, E. cloacae P99 and Citrobacter
freundii enzymes. It is composed of a mixed a/b sec-
ondary structure with nine-stranded antiparallel b sheets
in the middle flanked by a row of three a helices on one
side, and a helical domain with 11 helices on the other.
The primary catalytic residue (Ser64), which is acylated in
the course of the enzymatic hydrolysis, is positioned at the
N-terminal end of a buried central helix (fig. 2).
Structural similarities are also found between the various
class C b-lactamases, class A b-lactamases and b-lactam-
sensitive D-analyl-D-alanine carboxy-peptidase/transpep-
tidase (DD-peptidase) [24].
In the apo structure of E. cloacae 908R, a water molecule
occupies the so-called oxyanion hole and is held by two
strong hydrogen bonds involving the main chain at
residues Ser318 and Ser64 (table 2). The combined
strength of both hydrogen bonds increases slightly from
class C to class A and could be related to the rates of dea-
cylation in the penicillins.
Complex with IAPB
Clear electron density connects the Og atom of the cat-
alytic serine Ser64 to the tetrahedral boron atom of the
phenyl boronic acid inhibitor, suggesting that a dative co-
valent bond is formed between IAPB and the enzyme
(fig. 3). One of the oxygen atoms (O1) of the boron
adduct sits in the ‘oxyanion hole’, forming direct hydro-
gen bonds to main-chain nitrogen atoms (table 2), as dis-
cussed below.
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Data collection and refinement statistics for the final
models for the free E. cloacae 908R structure at 2.1 Å 
resolution and the IAPB-bound structure at 2.3 Å resolu-
tion are reported in table 1. 
The structure of 908R class C b-lactamase was solved 
by molecular replacement using the program AMoRe 
[21] as implemented in the CCP4 program suite (Collab-
orative Computational Project, Number 4, 1994). Both
structures were refined by alterning conjugated gradient
least-squares cycles using the Shelxl program [22] 
and graphical modelling using the program Turbo-
Frodo [23]. An initial model of the IAPB inhibitor was
built and energy minimised using InsightII and Dis-
cover (MSI/biosym San Diego). In its isolated con-
formation, the boronic acid B(OH)2 function is planar, 
as expected. In the complex with E. cloacae 908R, a tetra-
hedral co-ordination of the boron atom is observed 
affecting the geometry of the inhibitor. Those modified 
internal co-ordinates of the inhibitor were translated 
into 1–2 and 1–3 distance restraints used in the refine-
ment process.
Table 1. Data collection and refinement statistics.
Wild type IAPB
Crystal data
Space group P21212 P21212




Wavelength (Å) 1.54179 1.54179
Highest resolution (Å) 2.00 2.24
Total reflections 81043 48365
Unique reflections 21420 11810
Observed reflections [I > 2s (I)] 19781 9588
Completeness (%) 82.7 88.6 
Rmerge (%) 10.9 12.8
Refinement
Resolution range (Å) 10–2.00 10–2.24
Number of protein atoms 2757 2757
Number of ligand atoms 0 14
Number of water molecules 81 47
Rcryst (observed/all data) (%) 21.2/21.9 20.4/22.6 
Rfreea (%) 26.9 28.1
R.m.s. deviations from restraints
Bond lengths (Å) 0.005 0.004
Bond angles (Å) 0.021 0.016
Average B factor
All protein atoms (Å2) 35.08 34.00
All ligand atoms (Å2) – 43.74
All water molecules (Å2) 47.19 37.83
Ramachadran plot b
Most favoured regions (%) 87.0 85.7
Additionally allowed region (%) 12.3 13.7
Generously allowed region (%) 0.7 0.7
Disallowed region (%) 0.0 0.0
a Free test subset represents 5% of total unique reflections.
b As defined by PROCHECK, Gly and Pro residues excluded.
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plexed structure, Gln120 is displaced by the inhibitor and
no longer interacts with Asn152. The lateral iodo-
acetamido chain is further stabilised by a hydrogen bond
between the carbonyl of the carboxamido group and
Gln120. Apart from these changes within the active site,
comparison of the refined structures of 908R, unliganded
and in complex with the boronic acid inhibitor, shows that
neither backbone nor side-chain conformations change
much upon complexation. 
Interestingly, the relative orientation of the inhibitor in-
side the active site of E. cloacae 908R is distinct from 
This covalent bond between IAPB and the protein is con-
sistent with the proposed mechanism of inhibition and
similar to that observed in other structures of AmpC com-
plexed with aryl boronic acid, as discussed further in the
text. The IAPB inhibitor makes a number of favourable in-
teractions with the protein (table 2). Atoms within hydro-
gen-bonding distance of the inhibitor include the main-
chain nitrogen of Ser64, and the backbone N and O atoms
of Ser318, which interact with one of the boronic oxygens
(O1). 
In the apo structure, the conformation of Gln120 is such
that it hydrogen bonds with Asn152 (table 2). In the com-
Figure 2. Overall structure of the E. cloacae 908R class C b-lactamase, with a closer view of the active site showing the active Ser64 and
residues Lys67, Gln120, Asn152, Tyr150 and Lys315.
F
Table 2. Selected geometric features in the active site of E. cloacae
















* Oxyanion water molecule. Figure 3. Interactions between IAPB and selected residues of the
active site of E. cloacae 908R. 
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Figure 4. Comparison of the relative orientation of phenyl boronic acids in the active site of class C b-lactamases (molecular surface rep-
resentation of the enzyme). Upper: E. coli AmpC with m-aminophenyl boronic acid. Middle: E. cloacae 908R with IAPB. Lower: E. cloa-
cae P99 with N-[(p-iodophenyl)acetyl]aminomethyl phosphate. 
F
that observed in the complex of E. coli AmpC with
m-aminophenyl boronic acid (fig. 4). In the latter struc-
ture, the m-amino group of the inhibitor makes an hydro-
gen bond with Asn346 and positions the phenyl ring close
to Thr31. By contrast, IAPB points in the opposite direc-
tion, the lateral iodo-acetamido chain being stabilised by
a hydrogen bond between the carbonyl of the carboxam-
ido group and Gln120. The inhibitor fits the binding site
of the protein well (molecular surface representation in
fig. 4). The terminal iodo methyl group is less stabilised.
Two distinct positions of the iodine atom were refined,
both with half occupancy.
The structure of the E. cloacae 908R-IAPB complex re-
sembles that of other class C b-lactamases in complex
with other small boronic acids. The E. cloacae 908R-
IAPB complex also shares similarities with the structure
of a phosphonate derivative of the E. cloacae P99 b-lac-
tamase (PDB code 1BLS; figure 4). In this structure, 
the inhibitor has phosphorylated the active-site serine 
with loss of the m-carboxyphenol leaving group. The re-
sulting N-[(p-iodophenyl)acetyl]aminomethyl phosphate
is positioned in the active site in such a way that the
arylacetamido side chain is placed as anticipated from
analogous b-lactamoyl complexes, with the amido group
hydrogen bonded to the backbone carbonyl of Ser318 and
to the amides of Gln120 and Asn152. One phosphonyl
oxygen atom is hydrogen bonded to main-chain NH
groups of Ser318 and Ser64, while the other oxygen is not
within hydrogen-bonding distance of any amino acid.
Tyr150 and Lys67 are closely associated with Og of
Ser64. This arrangement, similar to that observed in the
present structure, was interpreted in terms of the transition
state for breakdown of the tetrahedral intermediate in the
deacylation step of catalysis. In this mechanism,
Tyr150 phenol seems the most likely general acid, and
thus the corresponding phenoxide anion would be the gen-
eral base catalyst in acylation [17]. This view is in com-
plete agreement with recent mechanistic studies per-
formed on AmpC [11].
Comparison with other class C b-lactamases 
complexes with aryl boronic acids
As small aryl boronic acids inhibit class C b-lactamases
at sub-micromolar concentrations, different X-ray crystal
structures of complexes with boronic acid inhibitors are
available in the PDB data bank. Taking advantage of the
large amount of structural data available for these en-
zymes, statistical searches in the PDB were performed
with the Relibase program to compare the geometries 
of complexes and identify structural features of the 
binding site of class C b-lactamases (fig. 5). Complexes
with aryl boronic acids were investigated. From the sta-
tistical search with Relibase, apart from the structure of
cocaine esterase in complex with phenyl boronic acid
(PDB code 1JU3 [25]), aryl boronic acid ligands are ap-
parently not found in other structures deposited at the
PDB. This does not mean that the aryl boronic fragment
is specific for class C b-lactamase but probably reflects
the fact that no one has yet attempted to obtain complexes
between these compounds and other (serine active) en-
zymes. 
Analysis of the structures of complexes between class C
b-lactamases and aryl boronic acids reveals that, except
for the complex with m-aminophenyl boronic acid, orien-
tation of IAPB deduced from our structure is similar to
that observed with other aryl boronic acid transition-state
analogues. Indeed, comparison of the structures in figure
5 suggests that small aryl boronic acid inhibitors bind to
a well-defined cleft in the different class C b-lactamases.
This cleft has also been shown to bind the ubiquitous
R1 side chain of b-lactams [15, 18]. Much of this cleft is
left unoccupied by the small aryl boronic acids. With the
exception of one complex (PDB code 3BLS), all boronic
ligands adopt similar orientations in the protein binding
sites. Combination of structure-based design and in-par-
allel synthesis allowed rapid exploration, in AmpC, of 
this binding site whose role in recognition had not been
previously explored [15]. The resulting inhibitors differ
considerably from b-lactams but nevertheless inhibit the
enzyme well. The crystal structure of ETP [3-(4-benzene-
sulphonyl-thiophene-2-sulphonylamino)-phenylboronic
acid, Ki 83 nM] in complex with AmpC (PDB code
1GA9) is the first exploration of this highly conserved
cleft and provides valuable information for further design
against class C b-lactamases.
Comparison of the present structure of 908R complexed
to IAPB with complexes with other boronic acid inhibitors
and class C b-lactamases further reveals consensus bind-
ing sites. These sites were already identified and charac-
terised in previous studies, using a combination of crys-
tallographic data and computational approaches [15, 18].
Among these binding sites, the highly conserved oxyan-
ion hole recognises one hydroxyl group of the boronic
acid. The aryl ring of aryl boronic acids is also stabilised
by interactions with Asn152. Interestingly, in complexes
with b-lactams, this conserved residue defines a recogni-
tion site that interacts with the carbonyl oxygen in the
R1 side chain of b-lactams [18]. 
Statistical analysis of the geometry within these sites was
performed on the structures retrieved with the Relibase
(fig. 6). The geometry of the oxyanion described in this
work (table 2) is consistent with the distribution of dis-
tances given in figure 6a (D1 and D2 define the distances
between the hydroxyl group of the boronic inhibitor and
the main-chain nitrogen and oxygen atoms, respectively,
and correspond to N_Ser318–O1 and O_Ser318–O1 dis-
tances in the complex of 908R with IAPB). The geometry
of the aryl-amide interaction involving residue Asn152 is
given by the parameters D3, A1, A2 and T1 in figure 6b.
These parameters underline contacts (less than 4 Å) be-
tween the side chain of residue 152 and the aromatic ring
of the boronic inhibitors together with an axial approach
(A1 and A2 close to 90° and T1 close to 180°). In the
structure with IAPB, the corresponding parameters are:
D1 = 3.63 Å, D2 = 3.92 Å, A1 = 130.2°, A2 = 98.7°,
T1 = 161.4°. These values fall within the statistical distri-
bution.
Conclusion
The structure of the complex between IAPB and E. cloa-
cae 908R is consistent with the status of boronic acids as
transition-state analogues. 
Comparison with the structures of complexes with other
transition-state boronic acids and b-lactams confirms the
possibility of different binding modes within the binding
site of class C b-lactamases. The less-constrained active-
site geometry observed in different class C enzymes po-
tentially allows different possible mechanisms of inhibi-
tion. Recent mechanistical studies based on X-ray
structures on trapped reaction intermediates are in agree-
ment with this view. From the point of view of drug de-
sign, this opens interesting perspectives for potentially
modulating existing inhibitors to make them more selec-
tive for class C b-lactamases. 
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Figure 5. Results of the Relibase search for structures of complexes with aryl boronic acids. a The same relative orientation of the bind-
ing site has been retained, with the catalytic Ser64 at the top, and Tyr150 on the right. Only the structure of the binding site in chain A is
presented because the ligands in each active site (chains A and B) bind similarly. b The structure of benzothiophene boronic acid has been
added to the selection by similarity with the initial search fragment (‘benzene ring’ plus ‘boronic acid’). c Note the two distinct geometries
of the B(OH)2 groups: one, tetrahedral, covalently bound to the active-site catalytic serine and the other, planar, not forming any covalent
bond within the binding site.
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Figure 5 (continued).
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Figure 6. Statistical analysis of the geometry of complexes between class C b-lactamases and boronic acid inhibitors. (a) First hydroxyl
binding site, (b) Aryl-pi binding site.
a
b
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